Dec 16, 2013 8:30am EST OPKO Health to Expand Latin American Presence with Acquisition of Uruguayan Pharmaceutical Company
Nov 06, 2013 3:51pm EST Neovasc, an OPKO Supported Company, Reports That Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Function in Patients with Refractory Angina